Nathaniel David's most recent trade in Unity Biotechnology Inc was a trade of 10,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 21, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Unity Biotechnology Inc | Nathaniel E. David | Director | 21 Jun 2024 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | ||
| Unity Biotechnology Inc | Nathaniel E. David | Director | 23 Jun 2023 | 6,000 | 6,000 | - | - | Stock Option (Right to Buy) | ||
| Unity Biotechnology Inc | Nathaniel E. David | Director | 24 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | ||
| Unity Biotechnology Inc | Nathaniel David | Director | 24 Jun 2021 | 11,918 | 11,918 | - | - | Stock Option (Right to Buy) | ||
| Unity Biotechnology Inc | Nathaniel David | Director | 29 Jan 2021 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | ||
| Unity Biotechnology Inc | Nathaniel David | Director, President | 16 Dec 2020 | 1,700,000 | 624,703 (1%) | 3% | 5.2 | 8,908,000 | Common Stock, $0.0001 par value |